YAP1 and breast cancer: A critical finding was the frequent deregulation of the Hippo pathway signalling (with strong nuclear YAP/TAZ expression in 61.4% of patients), which is generally associated with aggressive tumour behaviour, poor prognosis, and resistance to therapy in breast cancer.